Evidence, not assurance
Compliance must be demonstrated through evidence, not verbal assurance.
Playbook
A structured approach to inspection readiness for pharmaceutical manufacturers, distributors, and MAHs operating in Kenya — documentation requirements, facility expectations, team preparation, and the gaps identified most often during PPB and WHO inspections.
01 — Core principles
Compliance must be demonstrated through evidence, not verbal assurance.
Inspectors evaluate systems, not individuals.
Documentation must be complete, current, and controlled.
Facilities must reflect consistent operational discipline, not temporary preparation.
02 — Documentation readiness
Ensure every one of the following is in place before an inspection date is confirmed — not after.
03 — Facility readiness
The facility either reflects the documentation or contradicts it. There is no third outcome.
Clean, organized, and clearly labeled.
Controlled access, with entry logged and reviewable.
With visible status labels showing current calibration state.
Continuous systems with alarms, and excursions investigated.
Current contracts, service reports, and trend review.
Equipment in place with evacuation plans displayed.
Quarantined, rejected, expired and returned goods physically separated.
04 — Team preparation
05 — Common findings
06 — Final readiness review
Conduct a mock audit two to four weeks before inspection. Document all findings and close gaps with CAPAs. Any closer and there is no time to correct what you find; any earlier and the evidence will have drifted by the time inspectors arrive.
Planning market entry?
A short scoping conversation tells you which PPB pathway applies, what your dossier is missing, and what the realistic timeline looks like.